Herbal treatments for alleviating premenstrual symptoms: A systematic review

Journal of Psychosomatic Obstetrics and Gynecology

Volumn 32, Issue 1, 2011, Pages 42-51

  Dante, Giulia ^a   Facchinetti, Fabio ^a  

^a UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

Author keywords

Crocus sativus; herbal remedies; Hypericum perforatum; Premenstrual syndrome; Vitex agnus castus

Indexed keywords

AGNUCASTON; ALPHA TOCOPHEROL; ASCORBIC ACID; BROMOCRIPTINE; CROCUS SATIVUS EXTRACT; CYCLODYNON; FLAVONOID; FLUOXETINE; GINKGO BILOBA EXTRACT; HERBACEOUS AGENT; HYPERFORIN; HYPERICIN; HYPERICUM PERFORATUM EXTRACT; NICOTINIC ACID; OENOTERA BIENNIS EXTRACT; PLACEBO; PLANT EXTRACT; PRIMROSE OIL; PYRIDOXINE; TERPENOID; UNCLASSIFIED DRUG; VITEX AGNUS CASTUS EXTRACT; ZINC SULFATE;

ANTIINFLAMMATORY ACTIVITY; CROCUS; DIAGNOSTIC TEST; DRUG EFFICACY; DRUG INDUCED HEADACHE; DRUG SAFETY; GINKGO BILOBA; HERBAL MEDICINE; HUMAN; HYPERICUM PERFORATUM; HYPOMANIA; IN VITRO STUDY; IN VIVO STUDY; INCREASED APPETITE; MEDICAL PRACTICE; MEDICINAL PLANT; MENSTRUAL IRREGULARITY; META ANALYSIS (TOPIC); MULTICENTER STUDY (TOPIC); MULTIPLE CYCLE TREATMENT; NAUSEA; OENOTERA BIENNIS; OUTCOME ASSESSMENT; PREMENSTRUAL DYSPHORIC DISORDER; PREMENSTRUAL SYNDROME; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; RISK REDUCTION; SEDATION; SIDE EFFECT; SYSTEMATIC REVIEW; UTERUS BLEEDING; VITEX AGNUS CASTUS;

FEMALE; HUMANS; PHYTOTHERAPY; PREMENSTRUAL SYNDROME; RANDOMIZED CONTROLLED TRIALS AS TOPIC; TREATMENT OUTCOME;

EID: 79751496374     PISSN: 0167482X     EISSN: 17438942     Source Type: Journal    
DOI: 10.3109/0167482X.2010.538102     Document Type: Review

References (65)

1. Reid R. Premenstrual syndrome. N Engl J Med 1991;324: 1208-1210.
2. ACOG Diagnostic Criteria for PMS. ACOG Practice Bulletin - Number 15, April 2000.
3. Mortola J. Premenstrual syndrome-pathophysiologic considerations. N Engl J Med 1998;338:256-257.
4. Singh BB, Berman BM, Simpson RL, Annechild A. Incidence of premenstrual syndrome and remedy usage: a national pr (Pubitemid 128548535)
5. American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 4th ed. Washington, DC: American Psychiatric Association; 1994. pp 715-718.
6. Halbreich U. The diagnosis of premenstrual syndromes and premenstrual dysphoric disorder-clinical procedures and research perspectives. Gynecol Endocrinol 2004;19:320.
7. O'Brien PM. Helping women with premenstrual syndrome. BMJ 1993;307:1471-1475. (Pubitemid 23351441)
8. Chrousos GP, Torpy DJ, Gold PW. Interactions between the hypothalamic-pituitary-adrenal axis and the female reproductive system: clinical implications. Ann Intern Med 1998;129:229-240. (Pubitemid 28377514)
9. Lopez LM, Kaptein AA, Helmerhorst FM. Oral contraceptives containing drospirenone for premenstrual syndrome. Cochrane Database Syst Rev 2009;15:CD006586.
10. Ford O, Lethaby A, Roberts H, Mol BW. Progesterone for premenstrual syndrome. Cochrane Database Syst Rev 2009;15:CD003415.
11. Brown J, O' Brien PM, Marjoribanks J, Wyatt K. Selective serotonin reuptake inhibitors for premenstrual syndrome. Cochrane Database Syst Rev 2009;15:CD001396.
12. Wyatt KM, Dimmock PW, Jones PW, Shaughn O, Brien PM. Efficacy of vitamin B-6 in the treatment of premenstrual syndrome: systematic review. BMJ 1999;318:1375-1381. (Pubitemid 29237827)
13. MacLennan AH, Wilson DH, Taylor AW. Prevalence and cost of alternative medicine in Australia. Lancet 1996;347: 569-573. (Pubitemid 26070738)
14. Corney RH, Stanton R. A survey of 658 women who report symptoms of premenstrual syndrome. J Psychosom Res 1991;35:471-482.
15. Lloyd KB, Hornsby LB. Complementary and alternative medications for women's health issues. Nutr Clin Pract 2009;24:589-608.
16. Himmel W, Schulte M, Kochen MM. Complementary medicine: are patients' expectations being met by their general practitioners? Br J Gen Pract 1993;43:232-235. (Pubitemid 23203914)
17. Eisenberg DM, Davis RB, Ettner SL, Appel S, Van Rompay M, et al. Trends in alternative medicine use in the United States, 1990-1997: results of a follow-up national survey. JAMA 1998;280:1569-1575. (Pubitemid 28520643)
18. Tesch BJ. Herbs commonly used by women. An evidencebased review. Am J Obstet Gynecol 2003;188:S44-S45.
19. Stevinson C, Ernst E. Complementary/alternative therapies for premenstrual syndrome: a systematic review of randomized controlled trials. Am J Obstet Gynecol 2001;185:227-235. (Pubitemid 32681823)
20. Whelan AM, Jurgens TM, Naylor H. Herbs, vitamins and minerals in the treatment of premenstrual syndrome: a systematic review. Can J Clin Pharmacol 2009;16:407-429.
21. Cho SH, Kim J. Efficacy of acupuncture in management of premenstrual syndrome: a systematic review. Complement Ther Med 2010;18:104-111.
22. Lampert N, Xu Y. Chinese herbal nephropathy. Lancet 2002;359:796-797.
23. Gruenwald J, Brendler T, Jaenicke C, editors. PDR for herbal medicines. 2nd edition. Montvale, New Jersey: Medical Economics Company; 2000.
24. Jadad AR, Carroll D, Moore A, McQuay H. Developing a database of published reports of randomised clinical trials in pain. Research Pain 1996:66:239-246. (Pubitemid 26283993)
25. Jadad AR, McQuay HJ. A high-yield strategy to identify randomized controlled trials for systematic reviews. Online J Curr Clin Trials 1993:27;Doc. No. 33.
26. Mortola JF, Girton L, Beck L, Yen SS. Diagnosis of premenstrual syndrome by a simple, prospective, and reliable instrument: the calendar of premenstrual experiences. Obstet Gynecol 1990;76:302-307. (Pubitemid 20227477)
27. Carver CS, Scheier MF, Weintraub JJ. Assessing coping strategies: a theoretically based approach. J Pers Soc Psychol 1989;56:267-283.
28. Gerhard I, Patek A, Monga B, Blank A, Gorkow C. Mastodynon (R) bei weiblicher Sterilitaet. Forsch Komplementarmed 1998;5:272-278.
29. Westphal LM, Polan ML, Trant AS, Mooney SB. A nutritional supplement for improving fertility in women: a pilot study. J Reprod Med 2004;49:289-293. (Pubitemid 38525190)
30. Cerin A, Collins A, Landgren BM, Eneroth P. Hormonal and biochemical profiles of premenstrual syndrome. Treatment with essential fatty acids. Acta Obstet Gynecol Scand 1993;72:337-343. (Pubitemid 23217056)
31. Halaska M, Raus K, Beles P, Martan A, Paithner KG. Treatment of cyclical mastodynia using an extract of Vitex agnus castus: results of a double-blind comparison with a placebo. Ceska Gynekol 1998;63:388-392. (Pubitemid 28495984)
32. Van Die MD, Bone KM, Burger HG, Reece JE, Teede HJ. Effects of a combination of Hypericum perforatum and Vitex agnus castus on PMs-like symptoms in late perimenopausal women: findings from a subpopulation analysis. J Altern Complement Med 2009;15:1045-1048.
33. Milewicz A, Gejdel E, Sworen H, Sienkiewicz K, et al. Vitex agnus castus extract in the treatment of luteal phase defects due to latent hyperprolactinemia. Results of a randomized placebo-controlled double-blind study Arzneimittelforschung 1993;43:752-756.
34. Ma L, Lin S, Chen R, Zhang Y, Chen F, Wang X. Evaluating therapeutic effect in symptoms of moderate-to-severe premenstrual syndrome with Vitex agnus castus (BNO 1095) in Chinese women. Aust NZJ Obstet Gynecol 2010;50:189-193.
35. Hunter JO, Wilson AJ. A double-blind controlled trial of gamma-linolenic acid (GLA) in the management of premenstrual gastrointestinal symptoms. Proceedings of 2nd International Symposium on Premenstrual, Postpartum and Menopausal Mood Disorders, Kiawah Island, South Carolina; 1987. Abstract 44.
36. Halaska M, Beles P, Gorkow C, Sieder C. Treatment of cyclical mastalgia with a solution containing a Vitex agnus castus extract: results of a placebo-controlled double-blind study. The Breast 1993;8:175-218.
37. Shellemberg R. Treatment for the premenstrual syndrome with agnus castus fruit extract: prospective, randomised, placebo controlled study. BMJ 2001;322:134-137.
38. Atmaca M, Kumru S, Tezcan E. Fluoxetine versus Vitex agnus castus extract in the treatment of premenstrual dysphoric disorder. Hum Psychopharmacol Clin Exp 2003;18:191-195. (Pubitemid 36526944)
39. Lauritzen CH, Reuter HD, Repges R, et al. Treatment of premenstrual tension syndrome with Vitex agnus castus: controlled, double-blind study versus pyridoxine. Phytomedicine 1997;4:183-189. (Pubitemid 127565762)
40. Turner S, Mills S. A double-blind clinical trial on a herbal remedy for premenstrual syndrome: a case study. Complement Ther Med 1993;1:73-77.
41. Kilicdag EB, Tarim E, Bagis T, Erkanli S, et al. Fructus agni casti and bromocriptine for treatment of hyperprolactinemia and mastalgia. Int J Gynecol Obstet 2004;85:292-293. (Pubitemid 38622569)
42. He Z, Chen R, Zhou Y, Geng L, Zhang Z, et al. Treatment for premenstrual syndrome with Vitex agnus castus: a prospective, randomized, multi-center placebo controlled study in China. Maturitas 2009;63:99-103.
43. Ma L, Lin S, Chen R, Zhang Y, Chen F, Wang X. Evaluating therapeutic effect in symptoms of moderate-to-severe premenstrual syndrome with Vitex agnus castus (BNO 1095) in Chinese women. Aust N Z J Obstet Gynaecol 2010;50:189-193.
44. Callender K, Mc Gregor M, Kirk P, Thomas CS. A double blind trial of evening primerose oil in the premenstrual syndrome: nervous symptoms subgroup. Hum Psychopharmacol 1988;3:57-61.
45. Khoo SK, Munro C, Battistutta D. Evening primrose oil and treatment of premenstrual syndrome. Med J Aust 1990;153:189-192. (Pubitemid 20241678)
46. Collins A, Cerin A, Coleman G, Landgren B-M. Essential fatty acids in the treatment of premenstrual syndrome. Obstet Gynecol 1993;81:93-98. (Pubitemid 23041710)
47. Puolakka J, Makirainen L, Viinikka L, Ylikorkala O. Biochemical and clinical effects of treating the premenstrual syndrome with prostaglandin synthesis precursors. J Reprod Med 1985;30:149-153. (Pubitemid 15090370)
48. Hicks SM, Walker AF, Gallagher J, Middleton RW, Wright J. The significance of ''nonsignificance'' in randomized controlled studies: a discussion inspired by a double-blinded study on St. John's wort (Hypericum perforatum L.) for premenstrual symptoms. J Altern Complement Med 2004;10:925-932. (Pubitemid 40179997)
49. Canning S, Waterman M, Orsi N, Ayres J, Simpson N, Dye L. The efficacy of Hypericum perforatum (St John's Wort) for the treatment of premenstrual syndrome. A randomized, doubleblind, placebo-controlled trial. CNS Drugs 2010;24:207-225.
50. Tamborini A, Taurelle R. Value of standardized Ginkgo biloba extract (Egb 761) in the management of congestive symptoms of premenstrual syndrome. Rev Fr Gynecol Obstet 1993;88:447-457. (Pubitemid 23291644)
51. Ozgoli G, Selselei EA, Mojab F, Majd HA. A randomized, placebo-controlled trial of Ginkgo biloba L. in treatment of premenstrual syndrome. J Altern Complement Med 2009;15:845-851.
52. Agha-Hosseini M, Kashani L, Aleyaseen A, Ghoreishi A, et al. Crocus sativus L. (saffron) in the treatment of premenstrual syndrome: a double-blind, randomised and placebo-controlled trial. BJOG 2008;115:515-519. (Pubitemid 351225159)
53. Jarry H, Leonhardt S, Gorkow C,Wuttke W. In vitro prolactin but not LH and FSH release is inhibited by compounds in extracts of Agnus castus: direct evidence for a dopaminergic principle by the dopamine receptor assay. Exp Clin Endocrinol 1994;102:448-454.
54. Rotblatt M, Ziment I, editors. Evidence-based herbal medicine. Philadelphia: Hanley & Belfus Publ; 2002.
55. Brush MG, Watson SJ, Horrobin DF, Manku MS. Abnormal essential fatty acid levels in plasma of women with premenstrual syndrome. Am J Obstet Gynecol 1984;150:363-366. (Pubitemid 14014030)
56. Graham J. Premenstrual syndrome: evening primrose oil. Thorsens 1984:36-40.
57. Shelton RC, Keller MB, Gelenberg A, et al. Effectiveness of St. John's Wort in major depression: a randomized placebo controlled trial. JAMA 2001;285:1978-1986. (Pubitemid 32366950)
58. Laakmann G, Schule C, Baghai T, et al. St. John's Wort in mild to moderate depression: the relevance of hyperforin for the clinical efficacy. Pharmacopsychiat 1998;31:54-59. (Pubitemid 28294226)
59. Pang Z, Pan F, He S. Ginkgo biloba L.: history, current status, and future prospects. J Altern Complement Med 1996;2:359-363. (Pubitemid 126488226)
60. McKenna DJ, Jones K, Hughes K. Efficacy, safety, and use of Ginkgo Biloba in clinical and preclinical applications. Altern Ther Health Med 2001;7:70-90. (Pubitemid 32822186)
61. Noorbala AA, Akhondzadeh S, Tamacebi-pour N, Jamshidi AH. Hydroalcoholic extract of Crocus sativus L. versus fluoxetine in the treatment of mild to moderate depression: a double-blind, randomized pilot trial. J Ethnopharmacol 2005;97:281-284. (Pubitemid 40222030)
62. Akhondzadeh S, Tamacebi-pour N, Noorbala AA, Amini H, Fallah Pour H, Jamshidi AH, et al. Crocus sativus L. in the treatment of mild to moderate depression: a double-blind, randomized and placebo controlled trial. Phytother Res 2005;19:25-29.
63. Wang Y, Han T, Zhu Y, Zheng CJ, Ming QL, Rahman K, Qin LP. Antidepressant properties of bioactive fractions from the extract of Crocus sativus L. J Nat Med 2010;64:24-30.
64. Monagle L, Dan A, Krogh V, Jossa F, Farinaro E, Trevisan M. Perimenstrual symptom prevalence rates: an Italian- American comparison. Am J Epidemiol 1993;138:1070-1081. (Pubitemid 24018124)
65. Borrelli F, Izzo AA. Herb-drug interactions with St John's wort (Hypericum perforatum): an update on clinical observations. AAPS J 2009;11:710-727.